Wernicke Encephalopathy Associated with Crohn’s Disease
Keywords:
Crohn’s disease, thiamine deficiency, Wernicke encephalopathy, Korsakoff syndromeAbstract
Poorly controlled Crohn’s disease is associated with several complications, including malabsorption of vitamins and minerals such as vitamin D, vitamin B12, and vitamin B1 (thiamine). Thiamine, among other vitamins, plays a crucial role in Adenosine Triphosphate formation as well as nerve propagation. Thiamine deficiency initially manifests as wet or dry beriberi but may lead to the devastating Wernicke–Korsakoff syndrome. In this report, we present a case of full-blown Wernicke encephalopathy associated with uncontrolled Crohn’s disease.An 18-year-old young man was admitted with a chief complaint of hematemesis for 2 weeks before admission. He was previously diagnosed with Crohn’s disease in the past year, with constipation as the predominant symptom, and has been taking mesalazine 500 mg twice daily. Esophagogastroduodenoscopy and colonoscopy re-evaluation showed a worsening picture of Crohn’s disease pangastritis. The patient experienced swelling in both legs, the scrotum, and the upper extremities during hospital admission. On day 14 of hospitalization, the patient fell into a state of confusion with visual and auditory hallucinations, ophthalmoplegia, and ataxia. A Brain MRI showed a typical picture of Wernicke encephalopathy. Intravenous thiamine was administered, and the patient regained consciousness. His clinical symptoms improved every day until he was discharged. Uncontrolled Crohn’s disease may have several complications that clinicians need to be aware of, including thiamine deficiency. Wernicke encephalopathy shows a devastating clinical picture, but with thiamine therapy, it may resolve before further deterioration leads to irreversible Korsakoff syndrome.References
Behzadi P, Behzadi E, Ranjbar R. The incidence and prevalence of Crohn’s disease in global scale. 2015 [cited 2022 Sep 12]; Available from: www.symbiosisonline.orgwww.symbiosisonlinepublishing.com
Pratama N, Abdullah M, Kansera DD, et al. Prevalence of Crohn's disease in endoscopic unit Cipto Mangunkusumo Hospital. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy [Internet]. 2011 Jan 8;12(2):85–8. Available from: http://ina-jghe.com/index.php/jghe/article/view/323
Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc [Internet]. 2006;81(11):1462.
Available from: https://pubmed.ncbi.nlm.nih.gov/17120402/
Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol [Internet]. 2012 Sep;107(9):1399–406. Available from: https://pubmed.ncbi.nlm.nih.gov/22777340/
Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, De Silva P, Korzenik JR, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology [Internet]. 2013;145(5):970–7. Available from: https://pubmed.ncbi.nlm.nih.gov/23912083/
Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol [Internet]. 2011 Apr;106(4):563–73. Available from: https://pubmed.ncbi.nlm.nih.gov/21468064/
Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc [Internet]. 2019 Jun 1;94(6):1065–72. Available from: https://pubmed.ncbi.nlm.nih.gov/31171116/
Ota Y, Capizzano AA, Moritani T, Naganawa S, Kurokawa R, Srinivasan A. Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings. Jpn J Radiol [Internet]. 2020 Sep 1;38(9):809–20. Available from: https://pubmed.ncbi.nlm.nih.gov/32390125/
Sharma S, Sumich PM, Francis IC, Kiernan MC, Spira PJ. Wernicke’s encephalopathy presenting with upbeating nystagmus. Journal of Clinical Neuroscience [Internet]. 2002;9(4):476–8. Available from: https://pubmed.ncbi.nlm.nih.gov/12217687/
Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke encephalopathy—clinical pearls. Mayo Clin Proc. 2019 Jun 1;94(6):1065–72.
Oudman E, Wijnia JW, Oey MJ, van Dam M, Postma A. Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports. J Neurol Sci. 2021 Jul 15;426.
Aikawa H, Watanabe IS, Furuse T, Iwasaki Y, Satoyoshi E, Watanabe IS, et al. Low energy levels in thiamine-deficient encephalopathy. J Neuropathol Exp Neurol [Internet]. 1984;43(3):276–87. Available from: https://pubmed.ncbi.nlm.nih.gov/6726285/
Medline ® Abstract for Reference 3 of “Overview of water-soluble vitamins” - UpToDate [Internet]. cited 2022 Sep 4. Available from: https://www.uptodate.com/contents/overview-of-water-soluble-vitamins/abstract/3
CK S, SR P, BA M, PR M. The thiamine-dependent hysteretic behavior of human transketolase: implications for thiamine deficiency. J Nutr [Internet]. 1995;125(2):604S-- 615S. Available from: https://pubmed.ncbi.nlm.nih.gov/7861245/
Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J [Internet]. 2014;44(9):911–5. Available from: https://pubmed.ncbi.nlm.nih.gov/25201422/
Zubaran C, Fernandes JG, Rodnight R. Wernicke-Korsakoff syndrome. Postgrad Med J [Internet]. 1997 Jan 1;73(855):27–31. Available from: https://pmj.bmj.com/content/73/855/27
Nishimoto A, Usery J, Winton Jc, Twilla J. High-dose Parenteral Thiamine in Treatment of Wernicke’s Encephalopathy: Case Series and Review of the Literature. In Vivo (Brooklyn). 2017;31(1).
Dingwall KM, Delima JF, Binks P, Batey R, Bowden SC. What is the optimum thiamine dose to treat or prevent Wernicke’s encephalopathy or Wernicke–Korsakoff syndrome? Results of a randomized controlled trial. Alcohol Clin Exp Res [Internet]. 2022 Jun 1;46(6):1133–47. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/acer.14843
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marco Vidor, Wirdasari Wirdasari, Virly Nanda Muzellina, Simon Salim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
